Ion Beam Applications SA reported revenue results for the nine months ended September 30, 2017. For the period, the company's revenue €217.3 million, down 3.6% compared to the same period in 2016.

The company confidence in its scheduled revenue recognition in the fourth quarter from its strong backlog of Proton Therapy and Other Accelerators, Dosimetry and Services projects. Expected revenue recognition from at least five proton therapy systems, for which contracts are not yet signed, but are in the final stages of negotiation.

For the fiscal year 2017, the company expected 5-10% revenue growth and a 0-5% REBIT margin.

For the fiscal year 2018/2019, the company expected 0-5% revenue growth and a 5-10% REBIT margin.

From 2020 onwards, the company expected 5-10% revenue growth and 13-15% REBIT margin.